Skip to main content

Day: September 10, 2021

Simply Better Brands Corp. continues to expand its U.S.-based distribution of TRUBAR™ into Costco

Women-founded, Women-led Nutrition Brand Introduces Dessert-inspired, Plant-Based Protein Bars in Select Costco Locations.TRUBAR ProductsTRUBAR ProductsVANCOUVER, British Columbia, Sept. 10, 2021 (GLOBE NEWSWIRE) — Simply Better Brands Corp. (the “Company” or Simply Better Brands”) (TSX Venture: SBBC) announced their newest retail expansion into Costco. Their plant-based protein bar, TRUBAR, introduces a first-of-its-kind food category, where delicious, dessert-inspired flavor meets clean and simple ingredients. TRUBARs will be available for a limited time in Costco Southeast Clubs, located in GA, TN, NC, SC, FL, MS and AL in the United States. Costco will be carrying a dual pack “Oh Oh Cookie Dough” and “Daydreaming About Donuts” flavors. “The entry into Costco builds upon our broad distribution...

Continue reading

Coherus Management to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

REDWOOD CITY, Calif., Sept. 10, 2021 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that senior management will present at the 23rd Annual H.C. Wainwright Global Investment Conference. The presentation will be made available at 7 a.m. ET on Tuesday, September 14, 2021, during the virtual conference. The audio portion of the presentation will be available on the investors’ page of the Coherus Biosciences website at http://investors.coherus.com. About Coherus BioSciencesCoherus is a commercial stage biopharmaceutical company with the mission to increase access to cost-effective medicines that can have a major impact on patients’ lives and to deliver significant savings to the health care system. Coherus’ strategy is to build a leading immuno-oncology franchise funded with cash generated by...

Continue reading

Disposal of stake in Property Partner

Octopus Titan VCT plc (“Company” or “Titan”) 10 September 2021 Disposal of stake in Property Partner The Board of Octopus Titan VCT plc is pleased to announce that Property Partner, the online trading platform for investing in property equity and loans, has been acquired by Better HoldCo, Inc. (“Better”), one of the fastest-growing digital homeownership companies in the U.S., today. The resulting cash proceeds attributable to Titan are not materially different from the value at which Titan currently holds its investment in Property Partner. The consideration will consist of 50% being paid in cash on completion, with the remainder to be released by the end of Q4 2022. This demonstrates the important role that Titan plays in investing in the people, ideas and industries that will help change the world. For further enquiries, please contact: Katherine...

Continue reading

Financial Calendar 2022 for The BANK of Greenland

To Nasdaq OMX Copenhagen 10. September 2021  Announcement No. 13/2021 Financial Calendar 2022 for The BANK of Greenland  Annual Report 2021   02 March 2022  Annual general meeting in Nuuk   29 March 2022  Interim Report – First Quarter 2022   10 May 2022  Interim Report – First Half 2022   17 August 2022  Interim Report – First Nine Months 2022   02 November 2022Immediately after the release of the result, the reports will be available on The BANK of Greenland’s website, www.banken.gl  Best RegardsThe BANK of Greenland  Contact: General Manager Martin Kviesgaard, tel.: +299 34 7802Attachment13.Finanskalender 2022_ENG

Continue reading

Lantheus Announces Presentation at the 2021 American Urological Association (AUA) Annual Meeting

Highlights Piflufolastat F 18’s Potential to Change Initial Risk Assessment and Intended Patient Management in High-Risk Prostate Cancer Identified Regional Lymph Node and/or Distant Metastases in 26.9% of Patients Prior to Definitive Therapy NORTH BILLERICA, Mass., Sept. 10, 2021 (GLOBE NEWSWIRE) — Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), an established leader and fully integrated provider committed to innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions to find, fight and follow serious medical conditions, announced that data from the OSPREY pivotal trial on the utility of piflufolastat F 18 (previously referred to as 18F-DCFPyL or PyL) during initial assessment on men with high risk prostate cancer were presented at the 2021 American Urological Association (AUA) Virtual Annual...

Continue reading

Ideal Power to Present at H.C. Wainwright 23rd Annual Global Investment Conference

AUSTIN, Texas, Sept. 10, 2021 (GLOBE NEWSWIRE) — Ideal Power Inc. (Nasdaq: IPWR), pioneering the development and commercialization of highly efficient and broadly patented B-TRAN™ bi-directional power switches, today announced that Dan Brdar, President and Chief Executive Officer, and Tim Burns, Chief Financial Officer, will present at the 23rd Annual H.C. Wainwright Global Investment Conference, taking place virtually September 13-15, 2021. Management will also host one-on-one meetings with investors throughout the event. The virtual presentation will be available starting at 7:00 a.m. Eastern Time on September 13, 2021. Registration for the event is accessible via www.hcwevents.com/annualconference. H.C. Wainwright 23rd Annual Global Investment Conference Presentation Date/Time: Virtual presentation will be available starting...

Continue reading

AzurRx BioPharma Activates New Clinical Trial Sites in India for Phase 2 RESERVOIR Trial Evaluating Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections

Phase 2 placebo-controlled clinical trial to confirm safety of FW-1022 and investigate its ability to remove SARS-CoV-2 virus from the GI tract BOCA RATON, Fla., Sept. 10, 2021 (GLOBE NEWSWIRE) — AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company specializing in the development of targeted non-systemic, therapies for gastrointestinal (GI) diseases, today announced the activation of seven (7) new clinical trial sites in India for the ongoing RESERVOIR trial evaluating FW-1022. FW-1022 is a proprietary oral tablet formulation of micronized niclosamide developed for the treatment of COVID-19-related GI infections. The seven new clinical trial sites in India, together with the existing eleven sites in the U.S. and the five trial sites recently added in the Ukraine, brings the total number of RESERVOIR trial...

Continue reading

Grove Inc. to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

HENDERSON, NV, Sept. 10, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Grove Inc. (the “Company” or “Grove”) (NASDAQ: GRVI), Nevada company engaging in the research, manufacturing, distribution, and marketing of CBD and hemp wellness-based products, today announced that Allan Marshall, Grove’s Chief Executive Officer, will present at the H.C. Wainwright 23rd Annual Global Investment Conference being held virtually on September 13-15, 2021. The prerecorded presentation will become available on Monday, September 13, 2021 at 7:00am ET. Management will also be available to participate in one-on-one meetings. Investors may register for the conference at this link, and may also view the presentation by visiting the Events and Presentations section of Grove’s website: https://groveinc.io/investor-relations/. The webcast will be archived...

Continue reading

Brooge Energy Announces Dates for First Half 2021 Results and Conference Call

NEW YORK, Sept. 10, 2021 (GLOBE NEWSWIRE) — Brooge Energy Ltd. (“Brooge Energy” or the “Company”) (NASDAQ: BROG), a midstream oil storage and service provider strategically located outside the Strait of Hormuz, in the Port of Fujairah in the United Arab Emirates (the “UAE”), today announced that it will release its financial results for the six months ended June 30, 2021 on Monday, September 13, 2021. The Company will host a conference call to discuss these results on Wednesday, September 15, 2021. Following management’s prepared remarks there will be a question-and-answer session to address any queries investors have regarding the Company’s reported results. Conference Call Information:Date: Wednesday, September 15, 2021Time: 8:00 a.m. ET/4:00 p.m. UAEDial-in Numbers: U.S.: 1-877-425-9470  International: 1-201-389-0878  UAE:...

Continue reading

Bridgeline CEO Ari Kahn to Speak at Taglich Brothers Annual Investment Conference

WOBURN, Mass., Sept. 10, 2021 (GLOBE NEWSWIRE) — Bridgeline Digital, Inc. (NASDAQ: BLIN), a cloud-based marketing technology software provider, announced today that the company would present at the Taglich Brothers 17th Annual Investment Conference at the TWA Hotel at JFK in New York on September 13th at 3:15 pm ET. “The Taglich Brothers Investment Conference is an excellent venue for Bridgeline to meet investors and share its recent success in growing sales and achieving profitability,” said Mr. Kahn. “With COVID-19, many investor conferences canceled, and we’re happy to see the Taglich team put in the effort to make this important event happen.” Bridgeline recently announced its Financial Results for the Third Quarter of Fiscal 2021 with 31% revenue growth with the guidance of 20% growth for its...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.